drugset / Trial / NCT00002334

A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment

NCT00002334

Phase 3 Completed 3000 enrolled Hoffmann-La Roche
Double-blindTreatment

Summary

To compare, in zidovudine (AZT)-naive patients, the safety, tolerance, and efficacy of saquinavir mesylate (Ro 31-8959) alone versus AZT alone versus AZT in combination with Ro 31-8959, zalcitabine (ddC), or both. To compare various disease markers among the different regimens.

Timeline

Start
Primary completion
Completion

Publications

  • Background Collier CA, Coombs RW, Schoenfeld DA, Bassett R, Hooper C, Timphone J, Baruch A, Corey L. A comparative study of saquinavir (SAQ), and zidovudine (ZDV) vs. ZDV and zalcitabine (ddC) vs. SAQ, ZDV, and ddC. Program Abstr Intersci Conf Antimicrob Agents Chemother. 1994 Oct 4-7:60

Drugs

EvaluationDrugModalityDoseRoute
Subject Saquinavir Small molecule
Subject Zalcitabine Small molecule
Subject Zidovudine Small molecule